{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T16:55:42Z","timestamp":1774889742231,"version":"3.50.1"},"reference-count":67,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2013,4,4]],"date-time":"2013-04-04T00:00:00Z","timestamp":1365033600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"DOI":"10.1371\/journal.ppat.1003300","type":"journal-article","created":{"date-parts":[[2013,4,4]],"date-time":"2013-04-04T22:19:05Z","timestamp":1365113945000},"page":"e1003300","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":45,"title":["The Pharmaco \u2013, Population and Evolutionary Dynamics of Multi-drug Therapy: Experiments with S. aureus and E. coli and Computer Simulations"],"prefix":"10.1371","volume":"9","author":[{"given":"Peter","family":"Ankomah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul J. T.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce R.","family":"Levin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2013,4,4]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.2010.1004","article-title":"Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel","volume":"304","author":"MA Thompson","year":"2010","journal-title":"JAMA : the journal of the American Medical Association"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"e120","DOI":"10.1371\/journal.pmed.0040120","article-title":"Why is long-term therapy required to cure tuberculosis?","volume":"4","author":"LE Connolly","year":"2007","journal-title":"PLoS medicine"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1007\/BF01745248","article-title":"Piperacillin\/tazobactam in the treatment of polymicrobial infections","volume":"20 Suppl 3","author":"SL Gorbach","year":"1994","journal-title":"Intensive care medicine"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"e394","DOI":"10.1161\/CIRCULATIONAHA.105.165564","article-title":"Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America","volume":"111","author":"LM Baddour","year":"2005","journal-title":"Circulation"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ijantimicag.2008.03.003","article-title":"Levofloxacin plus rifampicin conservative treatment of 25 early staphylococcal infections of osteosynthetic devices for rigid internal fixation","volume":"32","author":"J Barberan","year":"2008","journal-title":"International journal of antimicrobial agents"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1128\/AAC.01365-09","article-title":"Empiric combination antibiotic therapy is associated with improved outcome against sepsis due to Gram-negative bacteria: a retrospective analysis","volume":"54","author":"ST Micek","year":"2010","journal-title":"Antimicrobial agents and chemotherapy"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1128\/AAC.41.1.95","article-title":"Synergism between tobramycin and ceftazidime against a resistant Pseudomonas aeruginosa strain, tested in an in vitro pharmacokinetic model","volume":"41","author":"JG den Hollander","year":"1997","journal-title":"Antimicrobial agents and chemotherapy"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1128\/AAC.39.8.1797","article-title":"Pharmacodynamics of ceftazidime administered as continuous infusion or intermittent bolus alone and in combination with single daily-dose amikacin against Pseudomonas aeruginosa in an in vitro infection model","volume":"39","author":"DM Cappelletty","year":"1995","journal-title":"Antimicrobial agents and chemotherapy"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1128\/AAC.38.12.2702","article-title":"Pharmacodynamics of levofloxacin, ofloxacin, and ciprofloxacin, alone and in combination with rifampin, against methicillin-susceptible and -resistant Staphylococcus aureus in an in vitro infection model","volume":"38","author":"SL Kang","year":"1994","journal-title":"Antimicrobial agents and chemotherapy"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1128\/AAC.39.12.2832","article-title":"Comparative in vitro activities of LY191145, a new glycopeptide, and vancomycin against Staphylococcus aureus and Staphylococcus-infected fibrin clots","volume":"39","author":"SL Kang","year":"1995","journal-title":"Antimicrobial agents and chemotherapy"},{"key":"ref11","first-page":"53","article-title":"Efficacy of Single-Agent Therapy with Azlocillin, Ticarcillin, and Amikacin and Beta-Lactam Amikacin Combinations for Treatment of Pseudomonas-Aeruginosa Bacteremia in Granulocytopenic Rats","volume":"80","author":"DE Johnson","year":"1986","journal-title":"American Journal of Medicine"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1128\/AAC.28.6.735","article-title":"Comparative activities of piperacillin, ceftazidime, and amikacin, alone and in all possible combinations, against experimental Pseudomonas aeruginosa infections in neutropenic rats","volume":"28","author":"DE Johnson","year":"1985","journal-title":"Antimicrobial agents and chemotherapy"},{"key":"ref13","first-page":"92","article-title":"Azlocillin with and without an Aminoglycoside against Respiratory-Tract Infections in Children with Cystic-Fibrosis","author":"H Michalsen","year":"1981","journal-title":"Scandinavian Journal of Infectious Diseases"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/infdis\/147.3.559","article-title":"Clinical and Bacteriological Responses to 3 Antibiotic Regimens for Acute Exacerbations of Cystic-Fibrosis - Ticarcillin-Tobramycin, Azlocillin-Tobramycin, and Azlocillin-Placebo","volume":"147","author":"FJ Mclaughlin","year":"1983","journal-title":"Journal of Infectious Diseases"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000237759","article-title":"Antimicrobial Synergism in Therapy of Gram-Negative Rod Bacteremia","volume":"24","author":"ET Anderson","year":"1978","journal-title":"Chemotherapy"},{"key":"ref16","first-page":"96","article-title":"Antibiotic Synergism and Response in Gram-Negative Bacteremia in Granulocytopenic Cancer-Patients","volume":"80","author":"CA Dejongh","year":"1986","journal-title":"American Journal of Medicine"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1128\/AAC.2.6.470","article-title":"Clinical Significance of in-Vitro Synergism between Antibiotics in Gram-Negative Infections","volume":"2","author":"J Klasters","year":"1972","journal-title":"Antimicrobial agents and chemotherapy"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1093\/infdis\/134.3.271","article-title":"Synergism between Amikacin and Cefazolin against Klebsiella - Invitro Studies and Effect on Bactericidal Activity of Serum","volume":"134","author":"J Klastersky","year":"1976","journal-title":"Journal of Infectious Diseases"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"S433","DOI":"10.1093\/infdis\/135.Supplement_2.S433","article-title":"Comparative Effectiveness of Combinations of Amikacin with Penicillin-G and Amikacin with Carbenicillin in Gram-Negative Septicemia - Double-Blind Clinical-Trial","volume":"134","author":"J Klastersky","year":"1976","journal-title":"Journal of Infectious Diseases"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/0002-9343(77)90669-6","article-title":"Comparative Efficacy and Toxicity of Amikacin-Carbenicillin Versus Gentamicin-Carbenicillin in Leukopenic Patients - Randomized Prospective Trail","volume":"62","author":"WK Lau","year":"1977","journal-title":"American Journal of Medicine"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1001\/archinte.1951.03810030022002","article-title":"Studies on antibiotic synergism and antagonism; the interference of chloramphenicol with the action of penicillin","volume":"87","author":"E Jawetz","year":"1951","journal-title":"AMA archives of internal medicine"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1001\/archinte.1951.03810100073006","article-title":"Treatment of pneumococcic meningitis with penicillin compared with penicillin plus aureomycin; studies including observations on an apparent antagonism between penicillin and aureomycin","volume":"88","author":"MH Lepper","year":"1951","journal-title":"AMA archives of internal medicine"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1093\/jac\/46.6.973","article-title":"Antagonism between penicillin and erythromycin against Streptococcus pneumoniae in vitro and in vivo","volume":"46","author":"HK Johansen","year":"2000","journal-title":"The Journal of antimicrobial chemotherapy"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1086\/510393","article-title":"Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship","volume":"44","author":"TH Dellit","year":"2007","journal-title":"Clinical infectious diseases : an official publication of the Infectious Diseases Society of America"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/jac\/11.5.427","article-title":"The fractional inhibitory concentration (FIC) index as a measure of synergy","volume":"11","author":"MJ Hall","year":"1983","journal-title":"The Journal of antimicrobial chemotherapy"},{"key":"ref26","unstructured":"Lorian V (1996) Antibiotics in laboratory medicine. Baltimore: Williams & Wilkins. xvi, 1238 p. p."},{"key":"ref27","doi-asserted-by":"crossref","first-page":"3670","DOI":"10.1128\/AAC.48.10.3670-3676.2004","article-title":"Pharmacodynamic functions: a multiparameter approach to the design of antibiotic treatment regimens","volume":"48","author":"RR Regoes","year":"2004","journal-title":"Antimicrobial agents and chemotherapy"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"13977","DOI":"10.1073\/pnas.0805965105","article-title":"Accelerated evolution of resistance in multidrug environments","volume":"105","author":"M Hegreness","year":"2008","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1128\/AAC.00873-06","article-title":"Concentration-dependent synergy and antagonism within a triple antifungal drug combination against Aspergillus species: analysis by a new response surface model","volume":"51","author":"J Meletiadis","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1093\/jac\/12.6.555","article-title":"Synergy with double and triple antibiotic combinations compared","volume":"12","author":"MC Berenbaum","year":"1983","journal-title":"J Antimicrob Chemother"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"e1002487","DOI":"10.1371\/journal.ppat.1002487","article-title":"Two-drug antimicrobial chemotherapy: a mathematical model and experiments with Mycobacterium marinum","volume":"8","author":"P Ankomah","year":"2012","journal-title":"PLoS pathogens"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1128\/AAC.01309-07","article-title":"Quantitative assessment of combination antimicrobial therapy against multidrug-resistant Acinetobacter baumannii","volume":"52","author":"TP Lim","year":"2008","journal-title":"Antimicrobial agents and chemotherapy"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/ng1755","article-title":"Functional classification of drugs by properties of their pairwise interactions","volume":"38","author":"P Yeh","year":"2006","journal-title":"Nature genetics"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"12254","DOI":"10.1073\/pnas.1201281109","article-title":"Mechanism-independent method for predicting response to multidrug combinations in bacteria","volume":"109","author":"K Wood","year":"2012","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1146\/annurev.micro.112408.134306","article-title":"Persister cells","volume":"64","author":"K Lewis","year":"2010","journal-title":"Annual review of microbiology"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(00)74210-3","article-title":"Treatment of staphylococcal infections with penicillin - By intermittent sterilisation","volume":"2","author":"JW Bigger","year":"1944","journal-title":"Lancet"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1471-2180-13-25","article-title":"Quantitative analysis of persister fractions suggests different mechanisms of formation among environmental isolates of E. coli","volume":"13","author":"N Hofsteenge","year":"2013","journal-title":"BMC Microbiol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/nature10069","article-title":"Metabolite-enabled eradication of bacterial persisters by aminoglycosides","volume":"473","author":"KR Allison","year":"2011","journal-title":"Nature"},{"key":"ref39","first-page":"313","article-title":"Combinated effects I Announcement - Implements to the problem","volume":"114","author":"S Loewe","year":"1926","journal-title":"Naunyn-Schmiedebergs Archiv Fur Experimentelle Pathologie Und Pharmakologie"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/nrmicro2133","article-title":"Drug interactions and the evolution of antibiotic resistance","volume":"7","author":"PJ Yeh","year":"2009","journal-title":"Nature reviews Microbiology"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"e1003123","DOI":"10.1371\/journal.pgen.1003123","article-title":"Pharmacodynamics, Population Dynamics, and the Evolution of Persistence in Staphylococcus aureus","volume":"9","author":"PJ Johnson","year":"2013","journal-title":"PLoS Genet"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"3414","DOI":"10.1128\/AAC.00381-10","article-title":"Population dynamics of antibiotic treatment: a mathematical model and hypotheses for time-kill and continuous-culture experiments","volume":"54","author":"BR Levin","year":"2010","journal-title":"Antimicrobial agents and chemotherapy"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1146\/annurev.mi.03.100149.002103","article-title":"The Growth of Bacterial Cultures","volume":"3","author":"J Monod","year":"1949","journal-title":"Annual Review of Microbiology"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1128\/AAC.49.4.1483-1494.2005","article-title":"Phenotypic tolerance: antibiotic enrichment of noninherited resistance in bacterial populations","volume":"49","author":"C Wiuff","year":"2005","journal-title":"Antimicrobial agents and chemotherapy"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/jac\/dkg269","article-title":"The mutant selection window and antimicrobial resistance","volume":"52","author":"K Drlica","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/nrd1008","article-title":"Understanding biofilm resistance to antibacterial agents","volume":"2","author":"D Davies","year":"2003","journal-title":"Nat Rev Drug Discov"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000094668","article-title":"Principles of antibiotic penetration into abscess fluid","volume":"78","author":"C Wagner","year":"2006","journal-title":"Pharmacology"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/jac\/22.6.777","article-title":"Resistance of bacterial biofilms to antibiotics: a growth-rate related effect?","volume":"22","author":"MR Brown","year":"1988","journal-title":"The Journal of antimicrobial chemotherapy"},{"key":"ref49","unstructured":"CLSI (2005) Performance Standards for Antimicrobial Susceptibility Testing. Fifteenth Informational Supplement Clinical and Laboratory Standards Institute."},{"key":"ref50","first-page":"243","article-title":"Studies on Antibiotic Synergism and Antagonism - a Scheme of Combined Antibiotic Action","volume":"2","author":"E Jawetz","year":"1952","journal-title":"Antibiotics and Chemotherapy"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1086\/381972","article-title":"Clinical relevance of bacteriostatic versus bactericidal mechanisms of action in the treatment of Gram-positive bacterial infections","volume":"38","author":"GA Pankey","year":"2004","journal-title":"Clin Infect Dis"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"6191","DOI":"10.1128\/JB.01651-09","article-title":"Emergence of Pseudomonas aeruginosa strains producing high levels of persister cells in patients with cystic fibrosis","volume":"192","author":"LR Mulcahy","year":"2010","journal-title":"Journal of bacteriology"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1128\/AAC.00860-09","article-title":"Patients with long-term oral carriage harbor high-persister mutants of Candida albicans","volume":"54","author":"MD Lafleur","year":"2010","journal-title":"Antimicrobial agents and chemotherapy"},{"key":"ref54","first-page":"293","article-title":"Letting Sleeping dos Lie: Does Dormancy Play a Role in Tuberculosis?","volume":"64","author":"MC Chao","year":"2010","journal-title":"Annual Review of Microbiology, Vol 64, 2010"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1126\/science.284.5418.1318","article-title":"Bacterial biofilms: A common cause of persistent infections","volume":"284","author":"JW Costerton","year":"1999","journal-title":"Science"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/nature05685","article-title":"Antibiotic interactions that select against resistance","volume":"446","author":"R Chait","year":"2007","journal-title":"Nature"},{"key":"ref57","first-page":"3","article-title":"Evolution of Bacterial-Host Interactions: Virulence and the Immune Overresponse","author":"E Margolis","year":"2008","journal-title":"Evolutionary Biology of Bacterial and Fungal Pathogens"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.cell.2007.06.049","article-title":"A common mechanism of cellular death induced by bactericidal antibiotics","volume":"130","author":"MA Kohanski","year":"2007","journal-title":"Cell"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"4922","DOI":"10.1128\/AAC.00921-12","article-title":"Role of oxidative stress in persister tolerance","volume":"56","author":"Y Wu","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nchembio.915","article-title":"Signaling-mediated bacterial persister formation","volume":"8","author":"NM Vega","year":"2012","journal-title":"Nat Chem Biol"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"e1002359","DOI":"10.1371\/journal.ppat.1002359","article-title":"Evolution of multidrug resistance during Staphylococcus aureus infection involves mutation of the essential two component regulator WalKR","volume":"7","author":"BP Howden","year":"2011","journal-title":"PLoS Pathog"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1128\/AAC.43.2.287","article-title":"In vivo emergence of multidrug-resistant mutants of Pseudomonas aeruginosa overexpressing the active efflux system MexA-MexB-OprM","volume":"43","author":"I Ziha-Zarifi","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1128\/CMR.15.4.647-679.2002","article-title":"Interactions among strategies associated with bacterial infection: Pathogenicity, epidemicity, and antibiotic resistance","volume":"15","author":"JL Martinez","year":"2002","journal-title":"Clinical Microbiology Reviews"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1093\/jac\/20.3.452","article-title":"Acquisition of antibiotic resistance plasmids in vivo by extraintestinal Salmonella spp","volume":"20","author":"JV Martinez-Suarez","year":"1987","journal-title":"J Antimicrob Chemother"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1128\/IAI.57.7.2141-2148.1989","article-title":"General method for site-directed mutagenesis in Escherichia coli O18ac:K1:H7: deletion of the inducible superoxide dismutase gene, sodA, does not diminish bacteremia in neonatal rats","volume":"57","author":"CA Bloch","year":"1989","journal-title":"Infection and immunity"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1471-2180-2-35","article-title":"Dynamics of success and failure in phage and antibiotic therapy in experimental infections","volume":"2","author":"JJ Bull","year":"2002","journal-title":"BMC microbiology"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"e1000317","DOI":"10.1371\/journal.pbio.1000317","article-title":"Ciprofloxacin causes persister formation by inducing the TisB toxin in Escherichia coli","volume":"8","author":"T Dorr","year":"2010","journal-title":"PLoS biology"}],"container-title":["PLoS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.ppat.1003300","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,24]],"date-time":"2020-07-24T23:00:09Z","timestamp":1595631609000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1003300"}},"subtitle":[],"editor":[{"given":"Ralph R.","family":"Isberg","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,4,4]]},"references-count":67,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2013,4,4]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1003300","relation":{},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,4]]}}}